|
|
|
|
LEADER |
03728nam a2200781 4500 |
001 |
ocn166140842 |
003 |
OCoLC |
005 |
20180501121912.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
070820s2001 caua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d OCLCQ
|d CUSER
|d IDEBK
|d E7B
|d OCLCQ
|d COF
|d OCLCQ
|d AZU
|d BAKER
|d MERUC
|d OPELS
|d OCLCQ
|d GBVCP
|d OPELS
|d OCLCF
|d DEBBG
|d KUK
|d OCLCQ
|d HEBIS
|d OCLCQ
|d BUF
|d GrThAP
|
019 |
|
|
|a 56578687
|a 170957968
|a 326630876
|a 648269894
|a 742283831
|a 814451476
|a 823106979
|a 823827214
|a 823896706
|a 824088764
|a 824135149
|a 906046649
|a 1027346460
|
020 |
|
|
|a 9780080496900
|q (electronic bk.)
|
020 |
|
|
|a 0080496903
|q (electronic bk.)
|
020 |
|
|
|a 0121822419
|q (electronic bk.)
|
020 |
|
|
|a 9780121822415
|q (electronic bk.)
|
020 |
|
|
|a 1281011193
|
020 |
|
|
|a 9781281011190
|
035 |
|
|
|a (OCoLC)166140842
|z (OCoLC)56578687
|z (OCoLC)170957968
|z (OCoLC)326630876
|z (OCoLC)648269894
|z (OCoLC)742283831
|z (OCoLC)814451476
|z (OCoLC)823106979
|z (OCoLC)823827214
|z (OCoLC)823896706
|z (OCoLC)824088764
|z (OCoLC)824135149
|z (OCoLC)906046649
|z (OCoLC)1027346460
|
050 |
|
4 |
|a QP620
|b .D78 2001eb
|
060 |
|
4 |
|a QU 58
|
070 |
|
|
|a QP601
|b .M49 v. 340
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MMG
|2 bicssc
|
082 |
0 |
4 |
|a 615.7045
|2 22
|
049 |
|
|
|a TEFA
|
245 |
0 |
0 |
|a Drug-nucleic acid interactions /
|c edited by Jonathan B. Chaires, Michael J. Waring.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c ©2001.
|
300 |
|
|
|a 1 online resource (xxxiv, 705 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in enzymology ;
|v v. 340
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
505 |
0 |
|
|a Biophysical approaches -- Chemical and molecular biological approaches -- Enzymology and biological approaches.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a This volume consolidates the key methods for studying ligand-nucleic acid interactions into a convenient source. Techniques that are examined range from biophysical and chemical approaches to methods rooted in molecular and cell biology.
|
650 |
|
0 |
|a Nucleic acids.
|
650 |
|
0 |
|a Ligand binding (Biochemistry)
|
650 |
|
0 |
|a DNA-ligand interactions.
|
650 |
|
0 |
|a Molecular pharmacology.
|
650 |
|
6 |
|a Acides nucléiques.
|
650 |
|
6 |
|a Ligands (Biochimie)
|x Fixation.
|
650 |
|
6 |
|a Interactions ADN-ligands.
|
650 |
|
6 |
|a Pharmacologie moléculaire.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a DNA-ligand interactions.
|2 fast
|0 (OCoLC)fst00886615
|
650 |
|
7 |
|a Ligand binding (Biochemistry)
|2 fast
|0 (OCoLC)fst00998460
|
650 |
|
7 |
|a Molecular pharmacology.
|2 fast
|0 (OCoLC)fst01024822
|
650 |
|
7 |
|a Nucleic acids.
|2 fast
|0 (OCoLC)fst01041070
|
650 |
1 |
7 |
|a Nucleïnezuren.
|2 gtt
|
650 |
1 |
7 |
|a Geneesmiddeleninteracties.
|2 gtt
|
650 |
1 |
7 |
|a Interactie.
|2 gtt
|
650 |
1 |
7 |
|a Liganden.
|2 gtt
|
650 |
1 |
7 |
|a Ecological footprints.
|2 gtt
|
650 |
|
7 |
|0 (DE-588)4003115-9
|0 (DE-603)084999918
|a Arzneimittel
|2 gnd
|
650 |
|
7 |
|0 (DE-588)4064937-4
|0 (DE-603)085182168
|a Wechselwirkung
|2 gnd
|
650 |
|
7 |
|0 (DE-588)4172117-2
|0 (DE-603)085794414
|a Nucleinsäuren
|2 gnd
|
650 |
1 |
2 |
|a DNA
|x drug effects.
|
650 |
2 |
2 |
|a DNA
|x physiology.
|
650 |
2 |
2 |
|a DNA-Binding Proteins
|x drug effects.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Chaires, Jonathan B.
|
700 |
1 |
|
|a Waring, Michael J.
|
776 |
0 |
8 |
|i Print version:
|t Drug-nucleic acid interactions.
|d San Diego : Academic Press, ©2001
|z 0121822419
|z 9780121822415
|w (OCoLC)47703223
|
830 |
|
0 |
|a Methods in enzymology ;
|v v. 340.
|
856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00766879/340
|z Full Text via HEAL-Link
|